Iron Supplementation in Hip/Knee Surgery

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio82 enrolled

Overview

Randomized controlled trial to evaluate the efficacy of oral iron supplementation in reducing the prevalence of preoperative anemia in a cohort of 82 patients undergoing elective prosthetic hip or knee surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Orthopedic Disorder Hip Arthropathy Knee Arthropathy Anemia Iron Poor Blood

Interventions

Sucrosomial iron plus ascorbic acidDIETARY_SUPPLEMENT

A number of 41 subjects are supplemented with 30 mg of iron plus 70 mg of ascorbic acid daily for 30+/-5 days before orthopedic surgery.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Males and females * ASA 1, 2, or 3 * No neuropsychiatric conditions * Acceptance of informed consent * Elective prosthetic hip or knee surgery Exclusion Criteria: * ASA 4 * Present or past neuropsychiatric conditions * Hip or knee revision surgery * Use of iron as dietary supplement * Known erythrocytosis * Incompatible hypersensitivities * Iron metabolism disorders * Lymphoproliferative disorders

Locations (1)

IRCCS Istituto Ortopedico Galeazzi

Milan, Italy

Outcomes

Primary Outcomes

Change of blood hemoglobin levels

CHange of hemoglobin concentration (g/dl) from baseline and after 30 days +/- 5 days

Time frame: Baseline and 30 days +/- 5 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.